acetylcysteine has been researched along with Hyperhomocysteinemia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S; Khandelwal, M; Manglani, K; Singh, RR; Surolia, A; Vijayan, V | 1 |
| Birkner, E; Dobrakowski, M; Kasperczyk, A; Kasperczyk, S; Pawlas, N; Romuk, E; Rykaczewska-Czerwińska, M | 1 |
| Duan, Y; Kuang, D; Ni, J; Wang, G; Xiao, G; Zhao, X | 1 |
| Battastini, AM; Bergamin, LS; Coutinho-Silva, R; de Souza Wyse, AT; Morrone, FB; Zanin, RF | 1 |
| Bonaterra, G; Dugi, KA; Edler, L; Hildebrandt, W; Kinscherf, R; Sauer, R | 1 |
| Barrentine, LW; Curole, MV; Hara, J; Shankle, WR | 1 |
| Baas, P; Beijnen, JH; Keizer, RJ | 1 |
| De Santo, NG; Ingrosso, D; Lanza, D; Perna, AF; Pollastro, RM; Sepe, I | 1 |
| Abaterusso, C; Bellinghieri, G; Cirillo, G; Cirillo, M; Coppola, S; De Santo, NG; Di Iorio, B; Ingrosso, D; Lanza, D; Lupo, A; Perna, AF; Raiola, I; Raiola, P; Santoro, D; Satta, E; Savica, V; Sepe, I; Tirino, G; Violetti, E | 1 |
| Peters, WH; Raijmakers, MT; Roes, EM; Steegers, EA | 1 |
| Allen, R; Boger, R; Doshi, S; Goodfellow, J; Lewis, M; McDowell, I; Moat, S; Newcombe, R; Stabler, S | 1 |
| Davies, G; McCaddon, A | 1 |
| McCaddon, A | 1 |
| Capasso, R; De Santo, NG; Ingrosso, D; Lombardi, C; Luciano, MG; Perna, AF; Pulzella, P; Satta, E | 1 |
| Bolca, O; Cakmak, N; Nurkalem, Z; Onturk, E; Sahin, S; Sayar, N; Tangurek, B; Yilmaz, H; Yilmaz, M | 1 |
| Panini, R; Pasini, MC; Salvioli, G; Scarpetta, G; Ventura, P | 1 |
1 review(s) available for acetylcysteine and Hyperhomocysteinemia
| Article | Year |
|---|---|
Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies.
Topics: Acetylcysteine; Cardiovascular Diseases; Drug Resistance; Folic Acid; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Renal Dialysis; Risk Factors | 2012 |
5 trial(s) available for acetylcysteine and Hyperhomocysteinemia
| Article | Year |
|---|---|
Effect of N-acetylcysteine administration on homocysteine level, oxidative damage to proteins, and levels of iron (Fe) and Fe-related proteins in lead-exposed workers.
Topics: Acetylcysteine; Adult; Air Pollutants, Occupational; Anemia, Iron-Deficiency; Antioxidants; Dietary Supplements; Haptoglobins; Homocysteine; Humans; Hyperhomocysteinemia; Inhalation Exposure; Iron; Lead; Lead Poisoning; Male; Middle Aged; Occupational Diseases; Occupational Exposure; Oxidative Stress; Poland; Protein Carbonylation; Protoporphyrins; Transferrin | 2016 |
Oral N-acetylcysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status.
Topics: Acetylcysteine; Administration, Oral; Adult; Antihypertensive Agents; Antioxidants; Biotransformation; Cholesterol; Cysteine; Double-Blind Method; Glutathione; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Leukocytes, Mononuclear; Male; Middle Aged; Smoking; Triglycerides | 2015 |
Effects of oral N-acetylcysteine on plasma homocysteine and whole blood glutathione levels in healthy, non-pregnant women.
Topics: Acetylcysteine; Administration, Oral; Adult; Antioxidants; Dietary Supplements; Female; Glutathione; Homocysteine; Humans; Hyperhomocysteinemia | 2002 |
Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
Topics: Acetylcysteine; Adult; Arginine; Blood Flow Velocity; Brachial Artery; Cross-Over Studies; Cystathionine; Cysteine; Dipeptides; Double-Blind Method; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kinetics; Male; Methionine; Placebos; S-Adenosylhomocysteine; S-Adenosylmethionine; Vasodilation | 2005 |
Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease.
Topics: Acetylcysteine; Administration, Oral; Aged; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged | 2007 |
10 other study(ies) available for acetylcysteine and Hyperhomocysteinemia
| Article | Year |
|---|---|
Homocysteine alters the osteoprotegerin/RANKL system in the osteoblast to promote bone loss: pivotal role of the redox regulator forkhead O1.
Topics: Acetylcysteine; Animals; Cells, Cultured; Female; Forkhead Transcription Factors; Homocysteine; Hyperhomocysteinemia; Nerve Tissue Proteins; Osteoblasts; Osteoporosis; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; Protein Phosphatase 2; RANK Ligand; Rats; Rats, Sprague-Dawley | 2013 |
Hyperhomocysteinemia regulated SCF expression in cultured cardiomyocytes via modulation of NF-κB activities.
Topics: Acetylcysteine; Animals; Cell Movement; Cells, Cultured; Hyperhomocysteinemia; Myocytes, Cardiac; NF-kappa B; Rats; Rats, Sprague-Dawley; Stem Cell Factor | 2015 |
Pathological concentrations of homocysteine increases IL-1β production in macrophages in a P2X7, NF-ĸB, and erk-dependent manner.
Topics: Acetylcysteine; Animals; Antioxidants; Homocysteine; Hyperhomocysteinemia; Interleukin-1beta; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Reactive Oxygen Species; Receptors, Purinergic P2X7; Toll-Like Receptor 4 | 2015 |
CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Cerebral Cortex; Cerebrovascular Disorders; Dietary Supplements; Female; Humans; Hyperhomocysteinemia; Male; Middle Aged; Tetrahydrofolates; Vitamin B 12; Vitamin B Complex; White Matter | 2016 |
'Flooding' of the lungs and severe dyspnea in a patient with bronchoalveolar carcinoma.
Topics: Acetylcysteine; Adenocarcinoma, Bronchiolo-Alveolar; Administration, Inhalation; Administration, Oral; Dyspnea; Expectorants; Female; Humans; Hyperhomocysteinemia; Lung; Lung Diseases; Lung Neoplasms; Middle Aged; Nebulizers and Vaporizers; Risk Factors; Severity of Illness Index; Sputum | 2011 |
Therapy of hyperhomocysteinemia in hemodialysis patients: effects of folates and N-acetylcysteine.
Topics: Acetylcysteine; Aged; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2012 |
Co-administration of N-acetylcysteine, vitamin B12 and folate in cognitively impaired hyperhomocysteinaemic patients.
Topics: Acetylcysteine; Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Dietary Supplements; Drug Therapy, Combination; Female; Folic Acid; Humans; Hyperhomocysteinemia; Male; Memory Disorders; Memory, Short-Term; Treatment Outcome; Vitamin B 12 | 2005 |
Homocysteine and cognitive impairment; a case series in a General Practice setting.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Antioxidants; Cognition Disorders; Family Practice; Female; Folic Acid; Humans; Hyperhomocysteinemia; Male; Memory Disorders; Memory, Short-Term; Radiography; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B Complex | 2006 |
Is homocysteine toxic in uremia?
Topics: Acetylcysteine; Antitoxins; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Myocardial Infarction; Recurrence; Reference Values; Renal Dialysis; Retrospective Studies; Risk Factors; Uremia | 2008 |
N -Acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Cysteine; Female; Free Radical Scavengers; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged | 1999 |